Literature DB >> 12890928

FLJ14813 missense mutation: a candidate for autosomal dominant thrombocytopenia on human chromosome 10.

Manish J Gandhi1, Carrie L Cummings, Jonathan G Drachman.   

Abstract

The gene for a novel nonsyndromic autosomal dominant thrombocytopenia has been previously mapped to a region on human chromosome 10p11-12 (THC2, OMIM number *188000). This disorder is characterized by moderate thrombocytopenia and incomplete differentiation of megakaryocytes. We report here a novel missense mutation in the human gene FLJ14813 that segregates perfectly with thrombocytopenia in our kindred of 51 family members. The mutation is not detected in 94 random unrelated and unaffected individuals, nor is it reported in the Entrez single nucleotide polymorphism (SNP) database. A substitution of cytosine for guanidine (G to C) at nucleotide position 565 was present in all thrombocytopenic family members, causing a predicted substitution of aspartic acid for glutamic acid (E167D) in exon four.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12890928     DOI: 10.1159/000071812

Source DB:  PubMed          Journal:  Hum Hered        ISSN: 0001-5652            Impact factor:   0.444


  12 in total

1.  Loss of human Greatwall results in G2 arrest and multiple mitotic defects due to deregulation of the cyclin B-Cdc2/PP2A balance.

Authors:  Andrew Burgess; Suzanne Vigneron; Estelle Brioudes; Jean-Claude Labbé; Thierry Lorca; Anna Castro
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-10       Impact factor: 11.205

Review 2.  The nuts and bolts of AGC protein kinases.

Authors:  Laura R Pearce; David Komander; Dario R Alessi
Journal:  Nat Rev Mol Cell Biol       Date:  2010-01       Impact factor: 94.444

Review 3.  Genetics of familial forms of thrombocytopenia.

Authors:  Carlo L Balduini; Anna Savoia
Journal:  Hum Genet       Date:  2012-08-11       Impact factor: 4.132

4.  In vivo inactivation of MASTL kinase results in thrombocytopenia.

Authors:  H Jan Johnson; Manish J Gandhi; Ebrahim Shafizadeh; Nathaniel B Langer; Eric L Pierce; Barry H Paw; Diana M Gilligan; Jonathan G Drachman
Journal:  Exp Hematol       Date:  2009-05-19       Impact factor: 3.084

5.  Mutations in the 5' UTR of ANKRD26, the ankirin repeat domain 26 gene, cause an autosomal-dominant form of inherited thrombocytopenia, THC2.

Authors:  Tommaso Pippucci; Anna Savoia; Silverio Perrotta; Núria Pujol-Moix; Patrizia Noris; Giovanni Castegnaro; Alessandro Pecci; Chiara Gnan; Francesca Punzo; Caterina Marconi; Samuele Gherardi; Giuseppe Loffredo; Daniela De Rocco; Saverio Scianguetta; Serena Barozzi; Pamela Magini; Valeria Bozzi; Luca Dezzani; Mariateresa Di Stazio; Marcella Ferraro; Giovanni Perini; Marco Seri; Carlo L Balduini
Journal:  Am J Hum Genet       Date:  2011-01-07       Impact factor: 11.025

6.  Congenital amegakaryocytic thrombocytopenia: a brief review of the literature.

Authors:  Fatma S Al-Qahtani
Journal:  Clin Med Insights Pathol       Date:  2010-06-04

Review 7.  Inherited thrombocytopenias: history, advances and perspectives.

Authors:  Alan T Nurden; Paquita Nurden
Journal:  Haematologica       Date:  2020-06-11       Impact factor: 9.941

8.  Thrombocytopenia-associated mutations in Ser/Thr kinase MASTL deregulate actin cytoskeletal dynamics in platelets.

Authors:  Begoña Hurtado; Marianna Trakala; Pilar Ximénez-Embún; Aicha El Bakkali; David Partida; Belén Sanz-Castillo; Mónica Álvarez-Fernández; María Maroto; Ruth Sánchez-Martínez; Lola Martínez; Javier Muñoz; Pablo García de Frutos; Marcos Malumbres
Journal:  J Clin Invest       Date:  2018-10-29       Impact factor: 14.808

9.  [Mutation of ANKRD26 is responsible for thrombocytopenia 2 (THC2) : a family report in China].

Authors:  X F Liu; Y T Huang; Y F Chen; R F Fu; W Liu; F Xue; L Zhang; R C Yang
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2018-10-14

10.  The Cell Cycle Checkpoint System MAST(L)-ENSA/ARPP19-PP2A is Targeted by cAMP/PKA and cGMP/PKG in Anucleate Human Platelets.

Authors:  Elena J Kumm; Oliver Pagel; Stepan Gambaryan; Ulrich Walter; René P Zahedi; Albert Smolenski; Kerstin Jurk
Journal:  Cells       Date:  2020-02-18       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.